J9390 HCPCS code: Injection, vinorelbine tartrate, 10 mg
J9390 is the HCPCS Level II code for injection, vinorelbine tartrate, 10 mg. In 2024 Medicare paid an average of $6.04 per service for J9390 across 12,547 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 36 per day on outpatient hospital claims. Medicare volume fell 36% from 2022 to 2024 (19,475 to 12,547 services). In 2024, about 588 clinicians billed Medicare for J9390 for 375 beneficiaries; Florida, Texas, California accounted for 41% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 1996-01-01 |
| Last action effective | 2009-01-01 |
Who bills J9390 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 588 |
| Medicare beneficiaries | 375 |
| States with claims | 13 |
| Share of services in top 3 states (Florida, Texas, California) | 41% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9390, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 19,475 | 596 | $9.86 | $7.79 |
| 2023 | 16,117 | 480 | $7.99 | $6.30 |
| 2024 | 12,547 | 375 | $7.70 | $6.04 |
States with the most J9390 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 1,449 | $6.15 |
| Texas | 1,123 | $6.05 |
| California | 1,122 | $6.15 |
| Virginia | 896 | $6.04 |
| Maryland | 834 | $6.12 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 36 | Prescribing Information |
| practitioner claims | 36 | Prescribing Information |
What changed for J9390
- 1996-01-01: J9390 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9390?
J9390 is the HCPCS Level II code for injection, vinorelbine tartrate, 10 mg. Short descriptor: "Vinorelbine tartrate inj".
How much does Medicare pay for J9390?
In 2024, the average Medicare payment was $6.04 per service (average allowed $7.70).
Does Medicare cover J9390?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J9390 can be billed per day?
36 on outpatient hospital claims; 36 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9390
- Watch J9390 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9390
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.